Atlas Trials

ADARx Pharmaceuticals, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch ADARx Pharmaceuticals, Inc.

RecordFirmDate
Chinese Adults With Kidney Disease (NCT07522099)ADARx Pharmaceuticals, Inc.2026-05-21
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE) (NCT07428499)ADARx Pharmaceuticals, Inc.2026-04-02
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy (NCT06990269)ADARx Pharmaceuticals, Inc.2025-11-10
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease (NCT06989359)ADARx Pharmaceuticals, Inc.2025-08-28
STOP-HAE: A Phase 3 Study of ADX-324 in HAE (NCT06960213)ADARx Pharmaceuticals, Inc.2025-08-28
Phase 1 Study of ADX-626 in Healthy Participants (NCT07081503)ADARx Pharmaceuticals, Inc.2025-08-12
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension (NCT06205628)ADARx Pharmaceuticals, Inc.2024-03-21
Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients (NCT05876312)ADARx Pharmaceuticals, Inc.2023-08-07
Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients (NCT05691361)ADARx Pharmaceuticals, Inc.2022-12-14

Track ADARx Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.